Bio

Andrew is responsible for buy-side transaction execution, operational and strategic management of portfolio companies, and new investment sourcing. Andrew began his tenure at PGP in 2018 on the sell-side transaction advisory team and transitioned to PGP’s investment team in 2019. Andrew is an expert in strategic growth in the health care space and deeply familiar with the day-to-day challenges of managing growth stage companies. He works daily with portfolio company founders to formulate and implement strategic initiatives across all departments of the business. Andrew’s experience on both the advisory and investment teams at PGP has lent to exceptional knowledge of companies’ lifecycle from initial investment to successful exit.